ALB · Albemarle Corporation
$178.092026-05-17Sector: Basic Materials; Industry: Chemicals - Specialty; Sub-Industry: Specialty Chemicals
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$51
-71.3% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($23 · $60) Analysts Range ($136 · $216) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $3.3B | — | 16.0% | 12.8% | $464MM | −$298MM | $166MM | 10.2% | — | 6.1% | $7.6B | $1.05 | — |
| 2022.Q4 | $7.3B | 120.0% | 34.2% | 12.2% | $2.2B | −$2.5B | −$341MM | 10.6% | — | 25.4% | $9.7B | $22.85 | — |
| 2023.Q4 | $9.6B | 31.4% | 2.5% | 20.5% | $192MM | −$3.7B | −$3.5B | 10.1% | — | 1.7% | $12.7B | $13.37 | — |
| 2024.Q4 | $5.4B | -44.1% | -11.8% | 0.0% | −$689MM | $227MM | −$462MM | 11.9% | — | -5.5% | $12.3B | $-10.02 | — |
| 2025.Q4 | $5.1B | -4.4% | 1.7% | 0.0% | $134MM | $763MM | $897MM | 13.0% | — | 1.1% | $11.1B | $-4.34 | 235.3 |
| italics below = DCF projection · 10yr Rev CAGR: 8% |
| 2026.Q4 | $5.8B | +12.7% | 1.7% | 2.0% | $98MM | −$747MM | −$649MM | 11.9% | −$580MM | 0.9% | $11.9B | $0.84 | 212.0 |
| 2027.Q4 | $6.1B | +4.7% | 3.9% | 4.0% | $228MM | −$371MM | −$144MM | 11.6% | −$115MM | 1.9% | $12.2B | $1.93 | 92.3 |
| 2028.Q4 | $6.4B | +4.7% | 6.1% | 6.0% | $362MM | −$470MM | −$108MM | 11.2% | −$78MM | 2.9% | $12.7B | $3.08 | 57.8 |
| 2029.Q4 | $7.7B | +20.8% | 8.2% | 8.0% | $581MM | $0MM | $581MM | 10.9% | $377MM | 4.6% | $12.7B | $4.94 | 36.1 |
| 2030.Q4 | $9.0B | +17.1% | 12.6% | 10.0% | $1.0B | $0MM | $1.0B | 10.6% | $596MM | 8.0% | $12.7B | $8.63 | 20.6 |
|
| Term. Yr+ | $11.5B | 4.1% | 12.6% | 20.0% | $1.2B | −$552MM | $606MM | 8.6% | $5.0B | 8.6% | — | — | — |
Active scenario IV: $51 (-71.3% vs market)